Jens T. Siveke

14.6k citations

236 papers · 6.8k indexed · 1 hit paper · h-index 43

Oncology top 0.5%
Molecular Biology top 5%
Surgery top 2%
Cancer Research top 1%
Immunology top 2%

Co-authors: Alf Hamann Roland M. Schmid Paweł K. Mazur Günter Schneider Marija Trajkovic‐Arsic Florian Eckel Marcel Lee Bence Sipos
Topics: Pancreatic and Hepatic Oncology Research (108 papers)Cancer Genomics and Diagnostics (44 papers)Peptidase Inhibition and Analysis (26 papers)
Cited by: Oncology Cancer Research Immunology
Journals: Proceedings of the National Academy of Sciences Nucleic Acids Research Angewandte Chemie International Edition
Partner nations: Germany United States United Kingdom

In The Last Decade

Jens T. Siveke

223 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CellViT: Vision Transformers for precise cell segmentation and classification

2024 96 citations Constantin Seibold, Julius Keyl et al. Medical Image Analysis profile →

Peers

Countries citing papers authored by Jens T. Siveke

Since Specialization

Citations

This map shows the geographic impact of Jens T. Siveke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens T. Siveke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens T. Siveke more than expected).

Fields of papers citing papers by Jens T. Siveke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jens T. Siveke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens T. Siveke. The network helps show where Jens T. Siveke may publish in the future.

Co-authorship network of co-authors of Jens T. Siveke

This figure shows the co-authorship network connecting the top 25 collaborators of Jens T. Siveke. A scholar is included among the top collaborators of Jens T. Siveke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jens T. Siveke. Jens T. Siveke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prognostic Implications of⁶⁸Ga-FAPI-46 PET/CT–Derived Parameters on Overall Survival in Various Types of Solid Tumors 2024 ·Journal of Nuclear Medicine ·Masao Watanabe,Wolfgang P. Fendler,Hong Grafe,Nader Hirmas,Rainer Hamacher,(unknown),Kim M. Pabst,Hubertus Hautzel,Clemens Aigner,Stefan Kasper,Bastian von Tresckow,Martin Stuschke,Sherko Kümmel,(unknown),Boris Hadaschik,Viktor Grünwald,Fadi Zarrad,Jens T. Siveke,Ken Herrmann,Manuel Weber	9
2	Incidence and survival of patients with malignant pancreatic neuroendocrine neoplasms in Germany, 2009–2021 2024 ·Cancer Epidemiology ·Andreas Stang,(unknown),Bernd Holleczek,(unknown),Jacqueline Müller‐Nordhorn,Eunice Sirri,(unknown),Jens T. Siveke,Hiltraud Kajüter	2
3	CellViT: Vision Transformers for precise cell segmentation and classificationbreakdown → 2024 ·Medical Image Analysis ·(unknown),(unknown),(unknown),Constantin Seibold,Julius Keyl,Giulia Baldini,Selma Ugurel,Jens T. Siveke,Barbara T. Grünwald,Jan Egger,Jens Kleesiek	96
4	Fibroblast Activation Protein-Targeting Minibody-IRDye700DX for Ablation of the Cancer-Associated Fibroblast with Photodynamic Therapy 2023 ·Cells ·E. Smeets,(unknown),Gerben M. Franssen,(unknown),Cathelijne Frielink,Martijn W.J. Stommel,Marija Trajkovic‐Arsic,Phyllis F. Cheung,Jens T. Siveke,Ian A. Wilson,Alessandro Mascioni,Erik H.J.G. Aarntzen,Sanne A. M. van Lith	11
5	Histology-Based Prediction of Therapy Response to Neoadjuvant Chemotherapy for Esophageal and Esophagogastric Junction Adenocarcinomas Using Deep Learning 2023 ·JCO Clinical Cancer Informatics ·(unknown),Saskia Ting,Sven‐Thorsten Liffers,Kelsey L. Pomykala,Katja Steiger,Markus Albertsmeier,Martin K. Angele,Sylvie Lorenzen,Michael Quante,Wilko Weichert,Jan Egger,Jens T. Siveke,Jens Kleesiek	6
6	Superior Tumor Detection for⁶⁸Ga-FAPI-46 Versus¹⁸F-FDG PET/CT and Conventional CT in Patients with Cholangiocarcinoma 2023 ·Journal of Nuclear Medicine ·Kim M. Pabst,Marija Trajkovic‐Arsic,Phyllis F. Cheung,Simone Ballke,Katja Steiger,(unknown),Benedikt M. Schaarschmidt,Aleksandar Milošević,Robert Seifert,Michael A. Nader,Lukas Kessler,Jens T. Siveke,Katharina Lueckerath,Stefan Kasper,Ken Herrmann,Nader Hirmas,Hartmut Schmidt,Rainer Hamacher,Wolfgang P. Fendler	32
7	Smaller panel, similar results: genomic profiling and molecularly informed therapy in pancreatic cancer 2023 ·ESMO Open ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Marcel Wiesweg,Stefan Kasper,(unknown),Tobias Herold,(unknown),Brigitte Schumacher,(unknown),P. M. Markus,Jürgen Treckmann,Martin Schüler,Hans‐Ulrich Schildhaus,Jens T. Siveke	6
8	109P DNA damage repair pathways in biliary tract cancer: A new target for precision medicine? 2023 ·Annals of Oncology ·(unknown),(unknown),(unknown),(unknown),Tobias Herold,Stefan Kasper‐Virchow,Hans‐Ulrich Schildhaus,(unknown),Jens T. Siveke	1
9	SO-6 Changes in the course of advanced pancreatic cancer treatment with systemic chemotherapy: A pooled analysis of five clinical trials from two decades of clinical research within the German AIO Study-Group 2023 ·Annals of Oncology ·(unknown),Volker Heinemann,Laura Fischer,Frank Gieseler,Thomas Hoehler,Julia Mayerle,D. Quietzsch,Anke Reinacher‐Schick,Michael Schenk,G. Seipelt,Jens T. Siveke,Michael Stahl,Ursula Vehling‐Kaiser,Dirk Waldschmidt,Klara Dorman,(unknown),C. Benedikt Westphalen,Michael Haas,Stefan Boeck	1
10	Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer Entities 2022 ·Clinical Cancer Research ·Wolfgang P. Fendler,Kim M. Pabst,Lukas Kessler,Pedro Fragoso Costa,Justin Ferdinandus,Manuel Weber,(unknown),Katharina Lueckerath,Lale Umutlu,(unknown),(unknown),Martin Schüler,Marit Ahrens,Christoph Rischpler,Sebastian Bauer,Ken Herrmann,Jens T. Siveke,Rainer Hamacher	91
11	Tumor-associated hematopoietic stem and progenitor cells positively linked to glioblastoma progression 2021 ·Nature Communications ·I‐Na Lu,(unknown),Laurèl Rauschenbach,Sarah Teuber‐Hanselmann,(unknown),(unknown),Shruthi Prasad,Tobias Blau,Sied Kebir,Jens T. Siveke,Jürgen C. Becker,Ulrich Sure,Martin Glas,Björn Scheffler,Igor Cima	35
12	Poly(ADP‐ribose) polymerase inhibition in pancreatic cancer 2020 ·Genes Chromosomes and Cancer ·(unknown),Peter J. Bailey,Daniel Hübschmann,Anne Berger,John P. Neoptolemos,Dirk Jäger,Jens T. Siveke,Christoph Springfeld	15
13	Notch-Induced Myeloid Reprogramming in Spontaneous Pancreatic Ductal Adenocarcinoma by Dual Genetic Targeting 2018 ·Cancer Research ·Phyllis F. Cheung,(unknown),(unknown),(unknown),(unknown),Sven‐Thorsten Liffers,Kristina Althoff,Chang‐Lung Lee,Everett J. Moding,David G. Kirsch,Dieter Saur,Alexandr V. Bazhin,Marija Trajkovic‐Arsic,(unknown),Jens T. Siveke	8
14	Histone deacetylase class-I inhibition promotes epithelial gene expression in pancreatic cancer cells in a BRD4- and MYC-dependent manner 2017 ·Nucleic Acids Research ·Vivek Kumar Mishra,Florian Wegwitz,Robyn Laura Kosinsky,(unknown),Roland Baumgartner,(unknown),Jens T. Siveke,Hans‐Ulrich Schildhaus,Zeynab Najafova,Vijayalakshmi Kari,Hella Kohlhof,Elisabeth Heßmann,Steven A. Johnsen	65
15	Modeling Therapy Response and Spatial Tissue Distribution of Erlotinib in Pancreatic Cancer 2016 ·Molecular Cancer Therapeutics ·Barbara M. Grüner,I. Winkelmann,Annette Feuchtinger,Na Sun,Benjamin Balluff,Nicole Teichmann,Alexander Herner,(unknown),Katja Steiger,Rickmer Braren,Michaela Aichler,Iréne Esposito,Roland M. Schmid,Axel Walch,Jens T. Siveke	22
16	Co-clinical Assessment of Tumor Cellularity in Pancreatic Cancer 2016 ·Clinical Cancer Research ·Irina Heid,Katja Steiger,Marija Trajkovic‐Arsic,Marcus Settles,(unknown),Mert Erkan,Jörg Kleeff,Carsten Jäger,Helmut Friess,Bernhard Haller,(unknown),Roland M. Schmid,Markus Schwaiger,Ernst J. Rummeny,Iréne Esposito,Jens T. Siveke,Rickmer Braren	57
17	Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver 2016 ·Gastroenterology ·Barbara T. Grünwald,(unknown),Susanne Schaten,(unknown),(unknown),Bastian Höchst,(unknown),(unknown),Mert Erkan,Olga Prokopchuk,Marc E. Martignoni,Iréne Esposito,Mathias Heikenwälder,Aayush Gupta,Jens T. Siveke,Paul Säftig,Percy A. Knolle,Dirk Wohlleber,Achim Krüger	104
18	Selective In Vivo Imaging of Syngeneic, Spontaneous, and Xenograft Tumors Using a Novel Tumor Cell–Specific Hsp70 Peptide-Based Probe 2014 ·Cancer Research ·Stefan Stangl,Júlia Varga,(unknown),Marija Trajkovic‐Arsic,Jens T. Siveke,Florian R. Greten,Vasilis Ntziachristos,Gabriele Multhoff	26
19	Validation of Heat Shock Protein 70 as a Tumor-Specific Biomarker for Monitoring the Outcome of Radiation Therapy in Tumor Mouse Models 2014 ·International Journal of Radiation OncologyBiologyPhysics ·Christine Bayer,(unknown),Thomas E. Schmid,Marija Trajkovic‐Arsic,(unknown),Hanno M. Specht,Daniela Schilling,Mathias Gehrmann,Stefan Stangl,Jens T. Siveke,Jan J. Wilkens,Gabriele Multhoff	38
20	Notch2 is required for progression of pancreatic intraepithelial neoplasia and development of pancreatic ductal adenocarcinoma 2010 ·Proceedings of the National Academy of Sciences ·Paweł K. Mazur,Henrik Einwächter,Marcel Lee,Bence Sipos,Hassan Nakhai,Roland Rad,Ursula Zimber‐Strobl,Lothar J. Strobl,Freddy Radtke,Günter Klöppel,Roland M. Schmid,Jens T. Siveke	164

About Jens T. Siveke

Jens T. Siveke is a scholar working on Oncology, Cancer Research and Surgery, having authored 236 papers that have together received 6.8k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (108 papers), Cancer Genomics and Diagnostics (44 papers) and Peptidase Inhibition and Analysis (26 papers). The work is most often cited by research in Oncology (3.6k citations), Cancer Research (1.3k citations) and Immunology (1.2k citations). Jens T. Siveke has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Alf Hamann, Roland M. Schmid, Paweł K. Mazur, Günter Schneider, Marija Trajkovic‐Arsic, Florian Eckel, Marcel Lee, Bence Sipos, Annette Altmann and Uwe Haberkorn. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Angewandte Chemie International Edition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact